[Federal Register Volume 87, Number 19 (Friday, January 28, 2022)]
[Notices]
[Page 4564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01729]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-67-2021]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Authorization 
of Production Activity; AbbVie Ltd.; (Pharmaceutical Products); 
Barceloneta, Puerto Rico

    On September 24, 2021, AbbVie Ltd., submitted a notification of 
proposed production activity to the FTZ Board for its facility within 
Subzone 7I, in Barceloneta, Puerto Rico.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 54923, October 5, 2021). On 
January 24, 2022, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: January 24, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-01729 Filed 1-27-22; 8:45 am]
BILLING CODE 3510-DS-P